|
|
Noninvasive sensory stimulation to promote glymphatic-lymphatic clearance for the treatment of Alzheimer’s Disease |
| 1 R01 AT011460-01 |
TSAI, LI-HUEI |
NCCIH |
2021 |
|
|
Novel Path to Chronic Sensorimotor Dysfunction and Treatment for Chemotherapy |
| 5 R01 CA221363-04 |
COPE, TIMOTHY C |
NCI |
2021 |
|
|
Developmental regulation of apoptosis as a modifiable driver of radiotherapy-induced neurocognitive impairment in pediatric patients |
| 5 R37 CA248565-02 |
|
NCI |
2021 |
|
|
Development of a Universal Bi-ventricular Replacement System for the Failing Heart |
| 1 R01 HL153516-01A1 |
|
NHLBI |
2021 |
|
|
Elastic, Degradable Vascular Grafts with Helical Microfibers |
| 1 R01 HL159427-01 |
|
NHLBI |
2021 |
|
|
Emulating Immune Dysregulation by Trisomy 21 in a Multi-Organ-on-a-Chip System |
| 1 R01 HL159494-01 |
|
NHLBI |
2021 |
|
|
The Use of Blood Cells as a Biomarker in a Porcine Model of CO Poisoning with Evaluation of an Engineered Succinate-Prodrug |
| 1 R56 HL158696-01 |
|
NHLBI |
2021 |
|
|
Lasting Impacts: Dynamic, Fully Natural Bioprinted 3D Human Neurovascular Biomimetic Model to Study Traumatic Brain Injury Pathophysiology |
| 1 R61 HL159947-01 |
|
NHLBI |
2021 |
|
|
Targeting mitochondrial PARP1 in neuronal ischemia-reperfusion injury |
| 5 F30 HL142130-04 |
|
NHLBI |
2021 |
|
|
Role of Connexin43 in the heart and skeletal muscle in a model for Duchenne muscular dystrophy symptomatic carriers |
| 5 F31 HL151121-02 |
|
NHLBI |
2021 |
